Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases

Area of Science:

• Hepatology
• Mitochondrial Biology
• Metabolic Disorders

Background:

• Mitochondria are central to hepatic lipid metabolism and oxidative stress regulation.
• Dysfunctional mitochondria, characterized by lesions and impaired energy production, are implicated in various chronic liver diseases.
• Mitochondrial dysfunction contributes to steatosis, insulin resistance, and inflammation in liver pathologies.

Purpose of the Study:

• To review the critical role of mitochondrial processes in the pathogenesis of chronic liver diseases.
• To explore the mechanisms by which mitochondrial dysfunction drives liver disease progression.
• To discuss potential therapeutic strategies targeting mitochondrial pathways.

Main Methods:

• Literature review of studies on mitochondrial function in liver disease.
• Analysis of molecular and cellular mechanisms linking mitochondrial dysfunction to liver pathology.
• Synthesis of current understanding of therapeutic targets.

Main Results:

• Mitochondrial lesions, altered dynamics, and reduced ATP synthesis are hallmarks of liver disease.
• Impaired fatty acid oxidation and increased lipogenesis lead to hepatic steatosis.
• Mitochondrial reactive oxygen species mediate signaling pathways involved in insulin resistance, inflammation, and fibrosis.

Conclusions:

• Mitochondrial dysfunction is a key driver in the development and progression of nonalcoholic fatty liver disease, alcohol-associated liver disease, drug-associated liver disease, and viral hepatitis.
• Therapeutic interventions aimed at restoring mitochondrial function hold promise for treating chronic liver diseases.